|
|
Other links at Articles > Obstetrics and Gynecology |
| 4. |
Sorafenib and Bevacizumab Promising for Solid Tumors
|
|
|
Combination therapy with sorafenib and bevacizumab in patients with advanced solid tumors results in enhanced antitumor activity, particularly in those with epithelial ovarian cancer. Reuters Health Information
|
|
|